BioNTech Recognizes Staburo as Partner for Support in Developing Covid-19 Vaccine

Jan 8, 2021
Biontech Logo

BioNTech recognizes employees and partners for their support in developing historic vaccine.
We thank BioNTech for recognizing our biostatistics support in the development of a vaccine against COVID-19! We were very happy to add our expertise to this meaningful project and thank the whole team!

Link:

https://investors.biontech.de/news-releases/news-release-details/biontech-recognizes-employees-and-partners-their-support

Press release as pdf:

BioNTech Recognizes Employees and Partners for Their Support in Developing Historic Vaccine

More Articles

Staburo Expands its Clinical Data Management Capabilities 

Staburo Expands its Clinical Data Management Capabilities 

We have completed the development of our Clinical Data Management SOPs and supporting processes, which will take effect in mid-October 2026.  The new framework covers the full data management lifecycle and provides a consistent approach to the start-up, conduct...

read more